Rubber Stoppers for Injection Vials Standard Size 20mm 20-B2 Butyl Rubber Stoppers

PE package or TYVEK package, then pack into carton

We are the largest pharmaceutical glass packaging manufacturer in China, established in 1970 with a registered capital of approximately US$34,781,096 and total assets of over US$200 million. We have advanced manufacturing technology and expertise in our field. Our product range covers a wide range of containers for the storage and use of medicines, vaccines and other pharmaceutical preparations. We produce: Molded Injection Glass Vials, USP Type I, II, III, Glass Tubes, Ampoules, Tube Vials for Injection, USP Type I, Amber Glass Vials, Infusion Bottles, Cosmetic Bottles, (Nail Polish Bottles, Perfume Bottles) Cobalt Blue and green bottles for small food and beverage bottles, butyl rubber stoppers, aluminum plastic multi-caps, dropper bottle accessories. Prefilled glass syringes, dental glass cartridges. The scope covers nine series and 500 products of different specifications. Among them our molded glass vials and bottles comply with USP Type I, II, III. The annual output of leading products reaches more than 9 billion pieces. The products are sold to more than 700 domestic medical enterprises and exported to many provinces, cities, autonomous regions, Tibet and Taiwan. We export further in Asia. Products are sold in South Korea, Pakistan, the United States, Mexico, Spain, India, the Philippines, Italy, the United Arab Emirates, Thailand, Vietnam, Syria and other countries. The company took the lead in passing these two certifications in China. ISO9001 quality management system audit, and ISO14001 environmental management certification. We are now a public company. On June 3, 2002, the company's 32 million A shares were listed on the Shanghai Stock Exchange. The market is currently quite active and there are indications that our shares will appreciate in the short to medium term. We can say with confidence and a sense of accomplishment that we have opened a new chapter for the company's future development.